Discussion Our current results suggest that it is possible to identify susceptibility regions using this methodology. The presented method takes advantage.

Slides:



Advertisements
Similar presentations
The genetic dissection of complex traits
Advertisements

Yousaf Malik.  Mouse Embryonic Fibroblast (MEF) ◦ TDwt (cells containing the TDAG 51 gene) ◦ TDko (cells lacking the TDAG 51 gene)
An Introduction to the application of Molecular Markers
FDA Pharmacogenetic Labels A Clinical Perspective David A Flockhart MD, PhD Indiana University School of Medicine Clinical Pharmacology Subcommittee of.
V Dissecting the cellular response to DNA breaks using functional genomics Ásta Björk Jónsdóttir, Paul Russell, Alessandro Esposito, Tamara Gruener, Ashok.
REAL TIME PCR ………A step forward in medicine
Yan Guo Assistant Professor Department of Cancer Biology Vanderbilt University USA.
Presentation Title February 23, 2011 Establishing Clinical-grade Assays for Support of Drug Trials May 3, 2012 Patrick Hurban Expression Analysis.
16 November 2004Biomedical Imaging BMEN Biomedical Imaging of the Future Alvin T. Yeh Department of Biomedical Engineering Texas A&M University.
Modeling Depression in Mice to Identify Genetic Mechanisms of Mood Disorder Cristina Santos 1, Brooke Miller 2, Matthew Pletcher 2, Andrew Su 4, Lisa Tarantino.
Validity with Pragmatism Specific Issues in experimental design and implementation II-A.
Quantitative Genetics
Bull selection based on QTL for specific environments Fabio Monteiro de Rezende Universidade Federal Rural de Pernambuco (UFRPE) - Brazil.
Introduction of Cancer Molecular Epidemiology Zuo-Feng Zhang, MD, PhD University of California Los Angeles.
Luděk Bláha, PřF MU, RECETOX BIOMARKERS AND TOXICITY MECHANISMS 13 – BIOMARKERS Summary and final notes.
Haplotype Discovery and Modeling. Identification of genes Identify the Phenotype MapClone.
Genetic Analysis in Human Disease. Learning Objectives Describe the differences between a linkage analysis and an association analysis Identify potentially.
Strong Heart Family Study Phase VI Genetics Center Aims October 8, 2009.
Knowledgebase Creation & Systems Biology: A new prospect in discovery informatics S.Shriram, Siri Technologies (Cytogenomics), Bangalore S.Shriram, Siri.
Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3.
Introduction to Precision Medicine
Schematic of TIR signalling Cells as computational devices Contains 1 copy of the genome Contains ca protein molecules in a volume of.
: iPSC-CM were treated up to 4 weeks with T3 (3nm and 30nm). Gene expression of TH target genes and/or are key markers of cardiac maturation were assessed.
Chapter 13. The Impact of Genomics on Antimicrobial Drug Discovery and Toxicology CBBL - Young-sik Sohn-
Vs. home.ccr.cancer.gov Personalized medicine-The goal.
Utilizing Science & Technology and Innovation for Development A Genome Wide Association Study for Type 2 Diabetes Susceptibility Gene and Treatment in.
The Center for Medical Genomics facilitates cutting-edge research with state-of-the-art genomic technologies for studying gene expression and genetics,
Conservation of genomic segments (haplotypes): The “HapMap” n In populations, it appears the the linear order of alleles (“haplotype”) is conserved in.
ODD-Genes: Accelerating data-driven scientific discovery NeSC Review 2003 NeSC
Pharmacogenetics & Pharmacogenomics Personalized Medicine.
CS177 Lecture 10 SNPs and Human Genetic Variation
Experimental Design and Data Structure Supplement to Lecture 8 Fall
By: Amira Djebbari and John Quackenbush BMC Systems Biology 2008, 2: 57 Presented by: Garron Wright April 20, 2009 CSCE 582.
1 Image-Based Biomedical Big Data Analytics Jens Rittscher Department of Engineering Science, Nuffield Department of Medicine, University of Oxford.
Effects of metformin and thymoquinone on survival of leukemic cells
Kathleen Giacomini, Mark J. Ratain, Michiaki Kubo, Naoyuki Kamatani, and Yusuke Nakamura NIH Pharmacogenomics Research Network III & RIKEN Center for Genomic.
Chapter 22 - Quantitative genetics: Traits with a continuous distribution of phenotypes are called continuous traits (e.g., height, weight, growth rate,
Inflammatory Bowel Diseases November 19, 2007 NCDD Meeting Chair: Daniel K. Podolsky, MD Vice Chair: Eugene B. Chang, MD.
Genetics of Gene Expression BIOS Statistics for Systems Biology Spring 2008.
Systems Genetics Approach to the Study of Brain Iron Regulation Byron C. Jones Professor of Biobehavioral Health & Pharmacology The Pennsylvania State.
전통적인 신약 개발 과정.
Products > 3T3-L1 Transfection Reagent (Embryonic Fibroblast Cells, CL-173) Altogen Biosystems offers the 3T3-L1 Transfection Reagent among a host of 100+
Small Molecules that Enhance the Pharmacological Effects of Oligonucleotides Melissa Porter 1, Bing Yang 1, Canhong Cao 1, Xin Ming 1, Emily Hull-Ryde.
Pharmacogenetics/Pharmacogenomics. Outline Introduction  Differential drug efficacy  People react differently to drugs Why does drug response vary?
Brendan Burke and Kyle Steffen. Important New Tool in Genomic Medicine GWAS is used to estimate disease risk and test SNPs( the most common type of genetic.
Accelerating positional cloning in mice using ancestral haplotype patterns Mark Daly Whitehead Institute for Biomedical Research.
Fusarium-Induced Shoot Elongation Correlates with Seedling Lodging Rate and Root Reduction Natural Variation in Fusarium-Induced Morphological Changes.
Moiz Bakhiet, MD, PhD, Professor and Chairman
Single Nucleotide Polymorphisms (SNPs
SUNY Korea BioData Mining Lab - Journal Review
A multi-strain, high-resolution mouse haplotype map reveals three distinctive genetic signatures Laboratory of Population Genetics.
Naomi Ziv, Mark Siegal and David Gresham
Gene expression.
Mapping variation in growth in response to glucose concentration
Nuclear magnetic resonance NMR spectroscopy is a key analytical technique for structure elucidation of a wide range of materials from small molecules to.
Introduction to bioinformatics lecture 11 SNP by Ms.Shumaila Azam
mTORC1 regulates TFEB. (A) Lysosomal stress inhibits mTOR signalling.
Figure 1 Evolution of genetic concepts underlying risk of cardiovascular disease Figure 1 | Evolution of genetic concepts underlying risk of cardiovascular.
Lixia Yao, James A. Evans, Andrey Rzhetsky  Trends in Biotechnology 
Complex Traits Qualitative traits. Discrete phenotypes with direct Mendelian relationship to genotype. e.g. black or white, tall or short, sick or healthy.
The Zinc Ionophore PCI-5002 Radiosensitizes Non-small Cell Lung Cancer Cells by Enhancing Autophagic Cell Death  Kwang Woon Kim, PhD, Christina K. Speirs,
Understanding Multi-Environment Trials
Psychiatric Disorders: Diagnosis to Therapy
In these studies, expression levels are viewed as quantitative traits, and gene expression phenotypes are mapped to particular genomic loci by combining.
Personalized Medicine: Patient-Predictive Panel Power
Psychiatric Disorders: Diagnosis to Therapy
Chapter 7 Beyond alleles: Quantitative Genetics
Evan G. Williams, Johan Auwerx  Cell 
Volume 14, Issue 8, Pages (August 2007)
Introduction to Pharmacogenetics
Presentation transcript:

Discussion Our current results suggest that it is possible to identify susceptibility regions using this methodology. The presented method takes advantage of the large amount of phenotype data generated by high-content imaging and the detailed genotype information available for inbred mouse strains. This allows us to perform a high-throughput scan for QTLs affecting cytotoxic responses. This information, combined with the increasing amount of protein interaction and functional data available, can potentially help the discovery of genes involved in drug adverse reactions. Results We currently have 35 drugs screened that are in different stages of the image acquisition and analysis. We have not advanced to the point of QTL mapping yet. Partial results show some differences between strains in drug response (Figures 1 and 2). Methods We have screened embryonic fibroblasts from 32 inbred mouse strains with 35 toxicants/drugs in a high-content imaging screen that determines changes in specific cell-health status phenotypes (nuclear changes, membrane permeability, mitochondrial membrane potential and apoptosis). The phenotype data generated will be used in haplotype-based genome-wide association scans. The experimental design is outlined in the following sequence. Introduction Pharmacogenetic studies have successfully identified genetic variants that contribute to variation in susceptibility to drug responses, but it is still a complex and challenging task to evaluate broadly across the human genome to identify the genetic components of response to drugs. Despite limitations there is a pressing need to identify genetic components that contribute to the efficacy and toxicity of drugs, across a wide spectrum of agents. We have proposed that using an alternative model population approach will provide many underlying mechanisms and pathways that are implicated in drug activity and responses. We have developed a platform from genetically well defined mouse strains which will enable us to assess effects of toxicity and efficacy of current and novel agents in drug therapies. The use of inbred mouse strains has potential advantages in screening a large number of compounds for response variations. It is a genetically stable population that allows us to quickly perform association scans using available genotype information and the large amounts of phenotypic data generated by this project. Here, we present a new strategy to identify genes and gene pathways that underlie susceptibility to cellular-level adverse drug reaction. No targets have been validated yet, but we demonstrate the ability to multiplex cell-based assays for high- throughput QTL discovery. The cells are treated using 9 different drug concentrations, ranging from 15 nM to 100  M. Genome-wide association scans are used to discover QTLs involved in cytotoxic response. Candidate gene selection based on functional and expression information and validation. -logP Cumulative position SNPster (haplotype association mapping) Cell fixation and multiplex staining after 24 h and 72 h for high-content imaging analysis HoechstPermeability dye Mitochondria membrane potential Cytochrome c Control Cycloheximide 100  M Pharmacogenetics: In-vitro drug toxicity screening O. Suzuki 1, N. Butz 1, R. Singh 2, B. Steffy 1, D. Scoville 1, B. Parks 2, R. Thomas 2, T. Wiltshire 1 1) School of Pharmacy, University of North Carolina, Chapel Hill, NC; 2) The Hamner Institute for Health Sciences, Research Triangle Park, NC. NOR/LtJWSB/EiJ Some strains display markedly different responses to drug treatment Figure 2: Cell permeability dose-response curves (A) after 24h of treatment with Cycloheximide, showing differences between two inbred mouse strains. WSB/EiJ cells have increased cell permeability (B) after treatment with 100  M Cycloheximide for 24 h (green fluorescence). A) B) DNA content Cell membrane permeability Mitochondrial membrane potential changes Cell loss Nuclear morphology Cytochrome c localization and release from mitochondria Segmentation of acquired images and calculation of different parameters relevant to cytotoxic response: Mouse embryonic fibroblasts from 32 different inbred mouse strains are simultaneously grown and seeded onto single 384-well plates. Nonlinear regression and extraction of quantitative phenotypic data. Figure 1: Strains display different sensitivities to Cycloheximide after 24 h of treatment. Dose: log[Cycloheximide] (nM) Cell permeability Differences in dose-response curves between strains